Join us at the Antibody Engineering & Therapeutics event for the latest science and research on antibody engineering, design and selection diving into critical topics including Neurodegenerative Diseases, Tumor Microenvironment in Antibody Therapy, Antibody Immune Agonist, Bi-Specifics, ADCs, Protein-Based Degraders, Immuno-oncology, T-Cells, VHH and much more.

In our presentation, Antibody Sequence and Structure-based Workflows for Diversity and Developability Assessments, we will walk through sequence and structure-guided analyses of sdAbs from diverse public sources using tools such as Geneious Biologics. Clustering and visualizations of sdAbs based on CDR-H3 diversity and developability assessments will be presented, as well as a brief overview of the potential for AI to direct antibody engineering efforts.

Speakers include:

Vinodh Kurella, PhD
Senior Scientist
Takeda

Monica Watson, PhD
Field Application Scientist
Geneious Biologics, Dotmatics

Learn more about the Antibody Engineering & Therapeutics event.